iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
102 hedge funds and large institutions have $115M invested in iShares Genomics Immunology and Healthcare ETF in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
4.89% more ownership
Funds ownership: 27.54% → 32.43% (+4.9%)
Holders
102
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.44M | |
| 2 | +$4.94M | |
| 3 | +$3.44M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.2M |
| 5 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
+$2.05M |
Top Sellers
| 1 | -$7.2M | |
| 2 | -$4.2M | |
| 3 | -$1.26M | |
| 4 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
-$1M |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$991K |